KARLIN DAVID A 4
4 · PONIARD PHARMACEUTICALS, INC. · Filed Jun 18, 2007
Insider Transaction Report
Form 4
KARLIN DAVID A
Sr. VP, Clinical Devlpt & Reg
Transactions
- Award
Stock Option
2007-06-14+145,200→ 145,200 totalExercise: $3.66Exp: 2016-09-13→ Poniard Common Stock (145,200 underlying) - Award
Stock Option
2007-06-14+30,000→ 30,000 totalExercise: $5.98Exp: 2017-02-07→ Poniard Common Stock (30,000 underlying) - Award
Stock Option
2007-06-14+65,000→ 65,000 totalExercise: $8.14Exp: 2017-05-31→ Poniard Common Stock (65,000 underlying)
Footnotes (6)
- [F1]This stock option was approved on September 13, 2006 by the Equity Awards Subcommittee of the Compensation Committee of the Board of Directors, subject to shareholder approval of the amendment and restatement of the issuer's 2004 Incentive Compensation Plan, which the shareholders approved on June 14, 2007. The exercise price is equal to the closing market price of issuer's common stock on September 13, 2006, as adjusted for the one-for-six reverse stock split effected on September 22, 2006.
- [F2]This stock option vests (A) as to 50% of the total amount, in equal monthly amounts over four years from 9/13/06 and (B) as to 40% of the total amount, seven years after 9/13/06. 10% of the total amount vested on February 7, 2007.
- [F3]This stock option was approved on February 7, 2007 by the Equity Awards Subcommittee of the Compensation Committee of the Board of Directors, subject to shareholder approval of the amendment and restatement of the issuer's 2004 Incentive Compensation Plan, which the shareholders approved on June 14, 2007. The exercise price is equal to the closing market price of issuer's common stock on February 7, 2007.
- [F4]This stock option vests in equal monthly amounts over four years from February 7, 2007 in accordance with the issuer's 2004 Incentive Compensation Plan.
- [F5]This stock option was approved on May 31, 2007 by the Equity Awards Subcommittee of the Compensation Committee of the Board of Directors, subject to shareholder approval of the amendment and restatement of the issuer's 2004 Incentive Compensation Plan, which the shareholders approved on June 14, 2007. The exercise price is equal to the closing market price of issuer's common stock on May 31, 2007.
- [F6]This stock option vests in equal monthly amounts over four years from May 31, 2007 in accordance with the issuer's 2004 Incentive Compensation Plan.